LAVA Therapeutics NV Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2025-09-30..
Dividend safety
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -23.18M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2025-09-30 | (m) | $-23.18M | (m) |
| 2025-06-30 | (m) | $-28.32M | (m) |
| 2025-03-31 | (m) | $-27.98M | (m) |
| 2024-12-31 | (m) | $-25.11M | (m) |
| 2024-09-30 | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) |
| 2023-12-31 | (m) | $-41.87M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.